Stay Connected
Join us on Facebook Follow us on linked in Follow us on YouTube
About Us
GENERAL CAPABILITIES


VIEW NOW more
request info

Find out how our therapeutic and regulatory expertise in drug and medical device clinical development can help with your next study or program.

GO NOW more

News Releases

2014

Medpace to Present at Partnerships in Clinical Trials 2014: Argos Therapeutics and Medpace present lessons learned from an oncology rescue study

Cinven invests in Medpace, citing strong growth drivers in the CRO market

Medpace to Present at Outsourcing Clinical Trials – West Coast

Medpace Strengthens Global Oncology Drug Development Capabilities - Dr. Jamal Gasmi joins Medpace as Medical Director

Cardiac Safety Research Consortium (CSRC) Releases Cardiovascular Case Report Forms for use in Non Cardiovascular Clinical Trials

2013

MediTech Strategic Consultants B.V. changes name to Medpace Medical Device B.V.

Medpace recognized as a member of the Deloitte Cincinnati USA 100 for the 6th consecutive year

Medpace Deepens European Medical Expertise for Phase I-IV Cardiovascular and Metabolic Studies - Noted Cardiologist Dr. Linda van Campen Joins Medpace as a European Medical Director

Medpace publishes new white paper: The Role of the CRO in Effective Risk-Based Monitoring

Medpace to participate in panel discussion on “Overcoming Regulatory Hurdles to Regenerative Medicine” at Alliance for Regenerative Medicine’s Stem Cell Meeting on the Mesa

The Medpace Bioanalytical Laboratories Team presents Scientific Posters at 61st ASMS Conference on Mass Spectrometry Bioanalytical Laboratories team presents scientific posters at ASMS Conference

Subject Recruitment: Are You Prepared to Succeed? Peer Reviewed Article Published in Association of Clinical Research Professionals (ACRP) publication

Lessons Learned from the Use of Central Endoscopy Review in Inflammatory Bowel Disease Trials: Medpace Physicians Author Article that Summarizes Recent Developments

Dr. Alex Mescheder Joins Medpace as Vice President Medical and Regulatory Affairs, Europe - Medpace Continues its Aggressive European Expansion

2012

Medpace, Inc. acquires MediTech Strategic Consultants B.V., a European-based Contract Research Organization (CRO) Specializing in Medical Device

Medpace completes relocation of Medpace Reference Laboratories (MRL), doubling Medpace central laboratory capacity

Medpace completes construction on a new Clinical Pharmacology Unit - expanding Phase I-IIa clinical research capabilities

Medpace, Inc. hits 20 year mark as a full service, global CRO

"First-in-Human Phase 1 Studies in Oncology: The New Challenge for Investigative Sites" by Marc Salzberg, MD

Medpace announces the addition of Cheri Lindberg, MD, Medical Director, strengthening Medpace’s Therapeutic and Regulatory Expertise in Psychiatry

Medpace CEO and Founder, August J. Troendle, MD, accepts the Lifetime Achievement Award for Innovation from the Cincinnati USA Regional Chamber

Medpace welcomes Piotr Krzeski, MD, PhD, MFPM, Medical Director adding expertise in Gastroenterology

Medpace opens office in Lyon, France

Medpace announces the addition of Jason D. Hurt, MD, Medical Director, strengthening Medpace Therapeutic Expertise in Gynecologic Oncology

2011

Medpace strengthens European leadership and widens presence in Europe, opening two new offices in Scotland and Italy

Medpace Medical Device (MMD) announces the addition of Mike Winegar as Vice President, Regulatory Affairs

Medpace announces plans to enter into an equity recapitalization with affiliates of CCMP Capital Advisors, LLC

Medpace announces the addition of Brian Murphy, MD, MPH, Medical Director, strengthening Medpace’s Therapeutic Expertise in Infectious Disease and Pediatric Drug Development.

Medpace announces the addition of Dr. Jon Bruss, Medical Director, adding therapeutic expertise in infectious disease, antibiotics, anti-virals, vaccines, and pediatric medicines.